Joachim Schorr

Title: Innovations of Joachim Schorr

Introduction

Joachim Schorr is a notable inventor based in Hilden, Germany. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of five patents to his name, Schorr's work focuses on the use of nucleic acids as adjuvants in immunological applications.

Latest Patents

One of Schorr's latest patents is titled "Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant." This invention relates to methods and products that utilize a synergistic combination of immunostimulatory oligonucleotides containing unmethylated CpG dinucleotides and non-nucleic acid adjuvants. Such combinations can be used with an antigen or independently. Another significant patent is "Method of inducing an antigen-specific immune response by administering a synergistic combination of adjuvants comprising unmethylated CpG-containing nucleic acids and a non-nucleic acid adjuvant." This invention also emphasizes the use of immunostimulatory oligonucleotides for inducing cellular immunity, particularly in infants.

Career Highlights

Throughout his career, Schorr has worked with various organizations, including the University of Iowa Research Foundation. His expertise in immunology and adjuvant development has positioned him as a key figure in his field.

Collaborations

Some of Schorr's notable coworkers include Heather Lynn Davis and Arthur Mertz Krieg. Their collaborative efforts have contributed to advancements in immunological research and development.

Conclusion

Joachim Schorr's innovative work in the field of immunology, particularly through his patents on nucleic acids as adjuvants, showcases his significant contributions to science. His collaborations and career highlights further emphasize his impact in the field.